Trial intelligence / Profile preview

MAPLE: Intensified Treatment in Lupus Nephritis

NCT07760480Phase 4Recruiting

Sponsor
University of Amsterdam
Start
Apr 2026
Primary completion
Apr 2028
Countries
1
01

Overview

A Phase 4 trial of voclosporin in lupus nephritis (LN), sponsored by University of Amsterdam. Started Apr 2026; status: recruiting.

02

Drugs

voclosporin
03

Conditions

lupus nephritis (LN)

Beyond the preview

Go deeper on NCT07760480.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07760480.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call